Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Senseonics Holdings, Inc. - Common Stock (NY:SENS)

6.260 UNCHANGED

Last Price Updated: 8:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Senseonics Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Senseonics to Participate in Upcoming November Investor Conferences

November 08, 2021

From Senseonics Holdings, Inc.

Via Business Wire

7 Penny Stocks That Could Have an Explosive Year-End ↗

November 05, 2021

While meme trends are on the wane, these seven penny stocks still stand to make turbocharged moves higher in the short-term.

Via InvestorPlace

Senseonics Holdings, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 9, 2021, at 4:30 p.m. Eastern Time

October 26, 2021

From Senseonics Holdings, Inc.

Via Business Wire

Senseonics Stock Has a Huge Catalyst you Shouldn’t Sleep On ↗

October 25, 2021

If its its 180-day Eversense diabetes monitoring product gets approval, SENS stock should shift out of neutral.

Via InvestorPlace

FDA Approval for Senseonics’ Glucose Monitor Could Double the Stock Price ↗

October 18, 2021

SENS stock should follow a similar trajectory to DexCom, and if it does, it will likely explode in price following FDA approval.

Via InvestorPlace

Senseonics Announces Equity Grants To Employees Under Inducement Plan

October 04, 2021

From Senseonics Holdings, Inc.

Via Business Wire

Senseonics Stock Will Grow With Increased Product Awareness ↗

September 27, 2021

It has been a long road to commercializing the Eversense platform, but SENS stock holders should be glad to know that progress is being made.

Via InvestorPlace

18 Stocks Moving in Tuesday's Pre-Market Session ↗

September 21, 2021

Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44...

Via Benzinga

Senseonics Ready to Deliver More Than Just Hope? ↗

September 20, 2021

SENS stock is up 800% in the past 12 months, but a potential FDA approval could give shares a reason to go even higher.

Via InvestorPlace

Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio

September 13, 2021

From Senseonics Holdings, Inc.

Via Business Wire

Senseonics Stock Looks Like It Is Going to Stay Rangebound for a While ↗

September 13, 2021

It’s a risk to have one company account for much of your revenue. In the case of Senseonics, that’s a good thing for SENS stock.

Via InvestorPlace

Use Recent Rally to Take Profits in Senseonics ↗

September 13, 2021

Sensesonics has quite a ways to go before reaching commercial success.

Via InvestorPlace

Senseonics to Participate in the H.C. Wainwright Global Investment Conference

September 09, 2021

From Senseonics Holdings, Inc.

Via Business Wire

Why Shares of Senseonics Soared 30.6% in August ↗

September 08, 2021

The maker of continuous glucose monitoring systems for diabetes treatment is a meme stock with some fundamental support.

Via The Motley Fool

Senseonic Stock Is Climbing After Bouncing Back From a Disappointing Q2 ↗

September 02, 2021

Despite a mixed Q2 2021 result, bullish sentiment is building for Senseonics. Here’s why SENS stock can run up in the future.

Via InvestorPlace

There’s a Pullback Coming for Senseonics Stock, So Get Ready To Pounce ↗

September 01, 2021

Senseonics has massive potential to disrupt the fast-growing CGM market but SENS stock is significantly overvalued at this point.

Via InvestorPlace

As Senseonics Stock Stays Elevated, Wait Before Buying ↗

August 27, 2021

Investors bullish on its Eversense catalyst should continue to sit tight for a better entry point with SENS stock

Via InvestorPlace

Senseonics Can Move Higher, but Competitive Concerns Abound ↗

August 25, 2021

Going up against blue-chip competitors in a contested arena will be a tough challenge for SENS stock.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021 ↗

August 19, 2021

Upgrades According to DA Davidson, the prior rating for PaySign Inc (NASDAQ:

Via Benzinga

Revenue Acceleration Will Lift Senseonics ↗

August 17, 2021

Senseonics is ready to launch Eversense CGM systems globally through its partner. Investors buying SENS stock now will get rewarded.

Via InvestorPlace

The Fundamentals of Senseonics Make No Sense ↗

August 12, 2021

Some investors probably got rich buying SENS stock when it was cheap and selling it when it skyrocketed. Good for them, but skip it now.

Via InvestorPlace

SENS Stock: 2 Big Reasons Senseonics Is Squeezing Higher ↗

August 12, 2021

Today, two key catalysts are driving interest once again in Senseonics and SENS stock as retail investors focus on institutional buying.

Via InvestorPlace

Senseonics Could Go Higher, Especially if It Nabs FDA Approval ↗

August 11, 2021

Senseonics looks interesting here, especially with possible FDA approval. SENS stock is worth 24% more at $4, or even $6-plus once its CGM rolls out.

Via InvestorPlace

Senseonics Shares Drop On Posting Wider Q2 Loss; Backs FY21 Revenue Outlook ↗

August 10, 2021

Senseonics Holdings Inc (NYSE: SENS) posted a second-quarter 2021 loss of $(180.3) million, seeing its bottom line plummet from a loss of just $(7.5) million last year...

Via Benzinga

28 Stocks Moving in Tuesday's Pre-Market Session ↗

August 10, 2021

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also...

Via Benzinga

85 Biggest Movers From Yesterday ↗

August 11, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...

Via Benzinga

54 Stocks Moving In Tuesday's Mid-Day Session ↗

August 10, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy...

Via Benzinga

Senseonics Holdings, Inc. Reports Second Quarter 2021 Financial Results

August 09, 2021

From Senseonics Holdings, Inc.

Via Business Wire

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

Senseonics Financials Don’t Support Its Billion-Dollar-Plus Market Cap ↗

August 03, 2021

Senseonics' revolutionary Eversense glucose monitor may be redefining diabetes treatment, but its current contribution doesn't justify SENS stock rich valuation.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Senseonics Holdings, Inc. - Common Stock (NY:SENS)

All News about Senseonics Holdings, Inc. - Common Stock